Further studies on intracellular trafficking of different AD-AID mutant proteins might help in elucidating mechanisms of disease pathogenesis in the setting of AD-HIGM2 compared to impaired expression and/or function of AID as the cause of disease in AR-AID deficiency. This evidence concerns the gene AICDA and Alzheimer disease.